DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Questions
Schema
Social Networks
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://www.nature.com/articles/s41467-025-59874-0, but it redirected us to https://www.nature.com/articles/s41467-025-59874-0. The analysis below is for the second page.

Title[redir]:
Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors | Nature Communications
Description:
Despite the STING-type-I interferon pathway playing a key role in effective anti-tumor immunity, the therapeutic benefit of direct STING agonists appears limited. In this study, we use several artificial intelligence techniques and patient-based multi-omics data to show that Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1), which hydrolyzes STING-activating cyclic GMP-AMP (cGAMP), is a safer and more effective STING-modulating target than direct STING agonism in multiple solid tumors. We then leverage our generative chemistry artificial intelligence-based drug design platform to facilitate the design of ISM5939, an orally bioavailable ENPP1-selective inhibitor capable of stabilizing extracellular cGAMP and activating bystander antigen-presenting cells without inducing either toxic inflammatory cytokine release or tumor-infiltrating T-cell death. In murine syngeneic models across cancer types, ISM5939 synergizes with targeting the PD-1/PD-L1 axis and chemotherapy in suppressing tumor growth with good tolerance. Our findings provide evidence supporting ENPP1 as an innate immune checkpoint across solid tumors and reports an AI design-aided ENPP1 inhibitor, ISM5939, as a cutting-edge STING modulator for cancer therapy, paving a path for immunotherapy advancements. While the STING-type-I interferon pathway plays a key role in anti-tumour immunity, current direct STING agonists have limited therapeutic benefit. Here, the authors identify ENPP1 as a safer and more effective STING-modulating target than direct STING agonism, and use an AI-based drug design platform to design the ENPP1-selective inhibitor ISM5939.

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month

Based on our best estimate, this website will receive around 80,479,999 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don't see any clear sign of profit-making.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Doi.org might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

enpp, ism, pubmed, cells, cancer, article, google, scholar, cgamp, tumor, fig, data, cas, cell, sting, expression, central, immune, human, tumors, analysis, inhibitor, activation, breast, assay, mice, supp, combination, gse, drug, inhibition, therapy, control, source, patients, pathway, agonists, treated, biological, antitumor, inhibitors, code, potential, response, cat, compounds, discovery, treatment, nature, therapeutic,

Topics {✒️}

=\frac{{{\mbox{fold}}-{\mbox{change}}}_{{\mbox{induced}}} }{{{\mbox{fold}}-{\mbox{change}}}_{{\mbox{positive nature portfolio tsp services limited privacy policy springer international publishing advertising rna-seq libraries open targets platform contract research organizations cancer-cell-produced immunotransmitter involved tumor-intrinsic epithelial-mesenchymal transition5 nature 564 nature 573 nature tumor-infiltrating t-cell death reprints patient-based multi-omics data irf3-deficient thp1-dual cells single-cell rna-seq data aging-based dual-purpose disease female balb/cann mice middle research design amp-glo luminescence-based assay reversing epithelial-mesenchymal transition open-label subtype-specific expression programs tumor-bearing mice ablates generative ai-aided discovery ecto-nucleotide pyrophosphatase/phosphodiesterase research trends research progress quanti-luc™ lucia kit messenger cyclic gmp-amp cyclic gmp–amp synthase additional π-π interactions pre-ranked gene lists boronic acid-based inhibitor radiation-induced anticancer immunity tumor-derived cgamp triggers single-cell rna sequencing efficient physics-based module cutting-edge sting modulator wider therapeutic index post-tumor cell seeding tumor-bearing mice studied single-cell rna-seq single cell rna-seq enpp3 contained tris-hcl

Questions {❓}

AI in small-molecule drug discovery: a coming wave?
[What are the reasons for patient preference?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors
         description:Despite the STING-type-I interferon pathway playing a key role in effective anti-tumor immunity, the therapeutic benefit of direct STING agonists appears limited. In this study, we use several artificial intelligence techniques and patient-based multi-omics data to show that Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1), which hydrolyzes STING-activating cyclic GMP-AMP (cGAMP), is a safer and more effective STING-modulating target than direct STING agonism in multiple solid tumors. We then leverage our generative chemistry artificial intelligence-based drug design platform to facilitate the design of ISM5939, an orally bioavailable ENPP1-selective inhibitor capable of stabilizing extracellular cGAMP and activating bystander antigen-presenting cells without inducing either toxic inflammatory cytokine release or tumor-infiltrating T-cell death. In murine syngeneic models across cancer types, ISM5939 synergizes with targeting the PD-1/PD-L1 axis and chemotherapy in suppressing tumor growth with good tolerance. Our findings provide evidence supporting ENPP1 as an innate immune checkpoint across solid tumors and reports an AI design-aided ENPP1 inhibitor, ISM5939, as a cutting-edge STING modulator for cancer therapy, paving a path for immunotherapy advancements. While the STING-type-I interferon pathway plays a key role in anti-tumour immunity, current direct STING agonists have limited therapeutic benefit. Here, the authors identify ENPP1 as a safer and more effective STING-modulating target than direct STING agonism, and use an AI-based drug design platform to design the ENPP1-selective inhibitor ISM5939.
         datePublished:2025-05-23T00:00:00Z
         dateModified:2025-05-23T00:00:00Z
         pageStart:1
         pageEnd:23
         license:http://creativecommons.org/licenses/by-nc-nd/4.0/
         sameAs:https://doi.org/10.1038/s41467-025-59874-0
         keywords:
            Cancer therapy
            Drug discovery
            Machine learning
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig8_HTML.png
         isPartOf:
            name:Nature Communications
            issn:
               2041-1723
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Congying Pu
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hui Cui
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Huaxing Yu
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xin Cheng
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Man Zhang
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luoheng Qin
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhilin Ning
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wen Zhang
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shan Chen
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuhang Qian
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Feng Wang
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ling Wang
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaoxia Lin
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David Gennert
               affiliation:
                     name:Suite 126
                     address:
                        name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frank W. Pun
               url:http://orcid.org/0000-0001-8801-6645
               affiliation:
                     name:Hong Kong Science Park
                     address:
                        name:Insilico Medicine Hong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Hong Kong, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Feng Ren
               url:http://orcid.org/0000-0001-9157-9182
               affiliation:
                     name:Pudong New Area
                     address:
                        name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                        type:PostalAddress
                     type:Organization
                     name:Suite 126
                     address:
                        name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
                        type:PostalAddress
                     type:Organization
                     name:6F International Renewable Agency (IRENA) Building
                     address:
                        name:Insilico Medicine AI, 6F International Renewable Agency (IRENA) Building, Masdar City, United Arab Emirates
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alex Zhavoronkov
               url:http://orcid.org/0000-0001-7067-8966
               affiliation:
                     name:Suite 126
                     address:
                        name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
                        type:PostalAddress
                     type:Organization
                     name:Hong Kong Science Park
                     address:
                        name:Insilico Medicine Hong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Hong Kong, China
                        type:PostalAddress
                     type:Organization
                     name:6F International Renewable Agency (IRENA) Building
                     address:
                        name:Insilico Medicine AI, 6F International Renewable Agency (IRENA) Building, Masdar City, United Arab Emirates
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Oral ENPP1 inhibitor designed using generative AI as next generation STING modulator for solid tumors
      description:Despite the STING-type-I interferon pathway playing a key role in effective anti-tumor immunity, the therapeutic benefit of direct STING agonists appears limited. In this study, we use several artificial intelligence techniques and patient-based multi-omics data to show that Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1), which hydrolyzes STING-activating cyclic GMP-AMP (cGAMP), is a safer and more effective STING-modulating target than direct STING agonism in multiple solid tumors. We then leverage our generative chemistry artificial intelligence-based drug design platform to facilitate the design of ISM5939, an orally bioavailable ENPP1-selective inhibitor capable of stabilizing extracellular cGAMP and activating bystander antigen-presenting cells without inducing either toxic inflammatory cytokine release or tumor-infiltrating T-cell death. In murine syngeneic models across cancer types, ISM5939 synergizes with targeting the PD-1/PD-L1 axis and chemotherapy in suppressing tumor growth with good tolerance. Our findings provide evidence supporting ENPP1 as an innate immune checkpoint across solid tumors and reports an AI design-aided ENPP1 inhibitor, ISM5939, as a cutting-edge STING modulator for cancer therapy, paving a path for immunotherapy advancements. While the STING-type-I interferon pathway plays a key role in anti-tumour immunity, current direct STING agonists have limited therapeutic benefit. Here, the authors identify ENPP1 as a safer and more effective STING-modulating target than direct STING agonism, and use an AI-based drug design platform to design the ENPP1-selective inhibitor ISM5939.
      datePublished:2025-05-23T00:00:00Z
      dateModified:2025-05-23T00:00:00Z
      pageStart:1
      pageEnd:23
      license:http://creativecommons.org/licenses/by-nc-nd/4.0/
      sameAs:https://doi.org/10.1038/s41467-025-59874-0
      keywords:
         Cancer therapy
         Drug discovery
         Machine learning
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41467-025-59874-0/MediaObjects/41467_2025_59874_Fig8_HTML.png
      isPartOf:
         name:Nature Communications
         issn:
            2041-1723
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Congying Pu
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hui Cui
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Huaxing Yu
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xin Cheng
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Man Zhang
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luoheng Qin
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhilin Ning
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wen Zhang
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shan Chen
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuhang Qian
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Feng Wang
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ling Wang
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaoxia Lin
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David Gennert
            affiliation:
                  name:Suite 126
                  address:
                     name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frank W. Pun
            url:http://orcid.org/0000-0001-8801-6645
            affiliation:
                  name:Hong Kong Science Park
                  address:
                     name:Insilico Medicine Hong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Hong Kong, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Feng Ren
            url:http://orcid.org/0000-0001-9157-9182
            affiliation:
                  name:Pudong New Area
                  address:
                     name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
                     type:PostalAddress
                  type:Organization
                  name:Suite 126
                  address:
                     name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
                     type:PostalAddress
                  type:Organization
                  name:6F International Renewable Agency (IRENA) Building
                  address:
                     name:Insilico Medicine AI, 6F International Renewable Agency (IRENA) Building, Masdar City, United Arab Emirates
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alex Zhavoronkov
            url:http://orcid.org/0000-0001-7067-8966
            affiliation:
                  name:Suite 126
                  address:
                     name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
                     type:PostalAddress
                  type:Organization
                  name:Hong Kong Science Park
                  address:
                     name:Insilico Medicine Hong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Hong Kong, China
                     type:PostalAddress
                  type:Organization
                  name:6F International Renewable Agency (IRENA) Building
                  address:
                     name:Insilico Medicine AI, 6F International Renewable Agency (IRENA) Building, Masdar City, United Arab Emirates
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Nature Communications
      issn:
         2041-1723
      volumeNumber:16
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Suite 126
      address:
         name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
         type:PostalAddress
      name:Hong Kong Science Park
      address:
         name:Insilico Medicine Hong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Hong Kong, China
         type:PostalAddress
      name:Pudong New Area
      address:
         name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
         type:PostalAddress
      name:Suite 126
      address:
         name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
         type:PostalAddress
      name:6F International Renewable Agency (IRENA) Building
      address:
         name:Insilico Medicine AI, 6F International Renewable Agency (IRENA) Building, Masdar City, United Arab Emirates
         type:PostalAddress
      name:Suite 126
      address:
         name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
         type:PostalAddress
      name:Hong Kong Science Park
      address:
         name:Insilico Medicine Hong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Hong Kong, China
         type:PostalAddress
      name:6F International Renewable Agency (IRENA) Building
      address:
         name:Insilico Medicine AI, 6F International Renewable Agency (IRENA) Building, Masdar City, United Arab Emirates
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Congying Pu
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Hui Cui
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Huaxing Yu
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Xin Cheng
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Man Zhang
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Luoheng Qin
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Zhilin Ning
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Wen Zhang
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Shan Chen
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Yuhang Qian
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Feng Wang
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Ling Wang
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Xiaoxia Lin
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
      name:David Gennert
      affiliation:
            name:Suite 126
            address:
               name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
               type:PostalAddress
            type:Organization
      name:Frank W. Pun
      url:http://orcid.org/0000-0001-8801-6645
      affiliation:
            name:Hong Kong Science Park
            address:
               name:Insilico Medicine Hong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Hong Kong, China
               type:PostalAddress
            type:Organization
      name:Feng Ren
      url:http://orcid.org/0000-0001-9157-9182
      affiliation:
            name:Pudong New Area
            address:
               name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
               type:PostalAddress
            type:Organization
            name:Suite 126
            address:
               name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
               type:PostalAddress
            type:Organization
            name:6F International Renewable Agency (IRENA) Building
            address:
               name:Insilico Medicine AI, 6F International Renewable Agency (IRENA) Building, Masdar City, United Arab Emirates
               type:PostalAddress
            type:Organization
      name:Alex Zhavoronkov
      url:http://orcid.org/0000-0001-7067-8966
      affiliation:
            name:Suite 126
            address:
               name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
               type:PostalAddress
            type:Organization
            name:Hong Kong Science Park
            address:
               name:Insilico Medicine Hong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Hong Kong, China
               type:PostalAddress
            type:Organization
            name:6F International Renewable Agency (IRENA) Building
            address:
               name:Insilico Medicine AI, 6F International Renewable Agency (IRENA) Building, Masdar City, United Arab Emirates
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
      name:Insilico Medicine Hong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Hong Kong, China
      name:Insilico Medicine Shanghai Ltd, 9F, Chamtime Plaza Block C, Lane 2889, Jinke Road, Pudong New Area, Shanghai, China
      name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
      name:Insilico Medicine AI, 6F International Renewable Agency (IRENA) Building, Masdar City, United Arab Emirates
      name:Insilico Medicine US Inc,1000 Massachusetts Avenue, Suite 126, Cambridge, USA
      name:Insilico Medicine Hong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Hong Kong, China
      name:Insilico Medicine AI, 6F International Renewable Agency (IRENA) Building, Masdar City, United Arab Emirates

Social Networks {👍}(2)

External Links {🔗}(722)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Prism.js
Zoom.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Crossref

6.26s.